Hypothesis:Biomarkers offer diagnosis, prognosis, monitoring, mechanisms and targets
Platforms for ATTRaCT:
- "Classical" candidate peptide approach (CVRI, SIgN)
- Proteomics (IMCB)
- microRNA discovery (CVRI, Biochemistry YLL SoM, ETPL)
- The "immunome" (STIIC, SIgN)
Applied across human cohorts and animal models